<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>53</viewCount><searchCount>0</searchCount></scores><additional><submitter>Nishimasu H</submitter><funding>NICHD NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NHGRI NIH HHS</funding><pagination>1259-1262</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6368452</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>361(6408)</volume><pubmed_abstract>The RNA-guided endonuclease Cas9 cleaves its target DNA and is a powerful genome-editing tool. However, the widely used Streptococcus pyogenes Cas9 enzyme (SpCas9) requires an NGG protospacer adjacent motif (PAM) for target recognition, thereby restricting the targetable genomic loci. Here, we report a rationally engineered SpCas9 variant (SpCas9-NG) that can recognize relaxed NG PAMs. The crystal structure revealed that the loss of the base-specific interaction with the third nucleobase is compensated by newly introduced non-base-specific interactions, thereby enabling the NG PAM recognition. We showed that SpCas9-NG induces indels at endogenous target sites bearing NG PAMs in human cells. Furthermore, we found that the fusion of SpCas9-NG and the activation-induced cytidine deaminase (AID) mediates the C-to-T conversion at target sites with NG PAMs in human cells.</pubmed_abstract><journal>Science (New York, N.Y.)</journal><pubmed_title>Engineered CRISPR-Cas9 nuclease with expanded targeting space.</pubmed_title><pmcid>PMC6368452</pmcid><funding_grant_id>R01 DK097768</funding_grant_id><funding_grant_id>DP1 MH100706</funding_grant_id><funding_grant_id>DP1 HL141201</funding_grant_id><funding_grant_id>R01 HD088412</funding_grant_id><funding_grant_id>P01 HD087157</funding_grant_id><funding_grant_id>R01 MH110049</funding_grant_id><funding_grant_id>RM1 HG006193</funding_grant_id><funding_grant_id>R01 HG009761</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Aburatani H</pubmed_authors><pubmed_authors>Ishiguro S</pubmed_authors><pubmed_authors>Yachie N</pubmed_authors><pubmed_authors>Hirano H</pubmed_authors><pubmed_authors>Okazaki S</pubmed_authors><pubmed_authors>Shi X</pubmed_authors><pubmed_authors>Hirano S</pubmed_authors><pubmed_authors>Ishitani R</pubmed_authors><pubmed_authors>Nishimasu H</pubmed_authors><pubmed_authors>Gao L</pubmed_authors><pubmed_authors>Noda T</pubmed_authors><pubmed_authors>Mori H</pubmed_authors><pubmed_authors>Nureki O</pubmed_authors><pubmed_authors>Gootenberg JS</pubmed_authors><pubmed_authors>Holmes B</pubmed_authors><pubmed_authors>Abudayyeh OO</pubmed_authors><pubmed_authors>Oura S</pubmed_authors><pubmed_authors>Ikawa M</pubmed_authors><pubmed_authors>Tanaka M</pubmed_authors><pubmed_authors>Seki M</pubmed_authors><view_count>53</view_count></additional><is_claimable>false</is_claimable><name>Engineered CRISPR-Cas9 nuclease with expanded targeting space.</name><description>The RNA-guided endonuclease Cas9 cleaves its target DNA and is a powerful genome-editing tool. However, the widely used Streptococcus pyogenes Cas9 enzyme (SpCas9) requires an NGG protospacer adjacent motif (PAM) for target recognition, thereby restricting the targetable genomic loci. Here, we report a rationally engineered SpCas9 variant (SpCas9-NG) that can recognize relaxed NG PAMs. The crystal structure revealed that the loss of the base-specific interaction with the third nucleobase is compensated by newly introduced non-base-specific interactions, thereby enabling the NG PAM recognition. We showed that SpCas9-NG induces indels at endogenous target sites bearing NG PAMs in human cells. Furthermore, we found that the fusion of SpCas9-NG and the activation-induced cytidine deaminase (AID) mediates the C-to-T conversion at target sites with NG PAMs in human cells.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Sep</publication><modification>2020-11-09T09:04:43Z</modification><creation>2019-08-04T07:14:33Z</creation></dates><accession>S-EPMC6368452</accession><cross_references><pubmed>30166441</pubmed><doi>10.1126/science.aas9129</doi></cross_references></HashMap>